Beacon Pointe Advisors »

Bioxcel Therapeutics shares owned by Beacon Pointe Advisors

Quarter-by-quarter ownership of Bioxcel Therapeutics (BTAI) shares owned by Beacon Pointe Advisors from 13F filings

Historical chart of Beacon Pointe Advisors investment in Bioxcel Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Bioxcel Therapeutics held by Beacon Pointe Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Bioxcel Therapeutics by Beacon Pointe Advisors

Quarter filed Position value Share count Share price at filing
2023-12-31 $890k 302k 2.95
2023-09-30 $763k 302k 2.53
2022-12-31 $6.5M 302k 21.48

More positions owned by Beacon Pointe Advisors

Apple (AAPL)
Lennox International (LII)
Microsoft Corporation Put Option (MSFT)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Ishares Tr Core S&p500 Etf (IVV)
Vanguard Index Fds Mid Cap Etf (VO)
Schwab Strategic Tr Us Lrg Cap Etf (SCHX)
NVIDIA Corporation (NVDA)
Vanguard Index Fds Value Etf (VTV)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Vanguard Index Fds Growth Etf (VUG)
Amazon Call Option (AMZN)
Vanguard Index Fds Total Stk Mkt (VTI)
Ishares Tr Core Us Aggbd Et (AGG)

View all positions for Beacon Pointe Advisors

Top funds holding Bioxcel Therapeutics

Vanguard Group
Beacon Pointe Advisors
Charles Schwab Investment Management
Citadel Advisors
Bank of New York Mellon
Arete Wealth Advisors
Bank of America Corporation
Bank Of Montreal
Millennium Management
Wells Fargo & Company
Virtu Financial
Squarepoint Ops
Tocqueville Asset Management
UBS Group
D. E. Shaw & Co

View all funds holding Bioxcel Therapeutics